SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April
Read MoreThe companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April
Read MoreNew Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland, March 15, 2024
Read MorePartnership will investigate the underlying disease mechanisms of multiple sclerosis (MS) with the potential of finding new relevant drug targets
Read MoreSOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and
Read MoreREYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ — Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland,
Read MoreSOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic
Read MoreThe SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov.
Read MoreReykjavik, ICELAND, Nov. 6, 2023 /PRNewswire/ — A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today in
Read MoreThe three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science
Read MoreScientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty
Read More